89R14542 SCL-D
 
  By: Shofner H.B. No. 3455
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to manufacturer disclosure requirements and liability for
  experimental drugs and devices.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter E, Chapter 431, Health and Safety
  Code, is amended by adding Section 431.118 to read as follows:
         Sec. 431.118.  EXPERIMENTAL DRUG OR DEVICE DISCLOSURE
  REQUIREMENTS; LIABILITY. (a) In this section, "experimental drug
  or device" means a drug or device that:
               (1)  is experimental or investigational; or
               (2)  has been approved by the United States Food and
  Drug Administration for emergency use.
         (b)  A manufacturer of an experimental drug or device shall
  provide to a purchaser of the drug or device a disclosure form that
  provides a consumer all information reasonably necessary for the
  consumer to make an informed decision on whether to use the drug or
  device, including possible adverse health effects of the drug or
  device, in a clear and coherent summary.
         (c)  A purchaser of an experimental drug or device shall
  provide the disclosure form described by Subsection (b) to a person
  to whom the purchaser sells the drug or device. A health care
  provider or retailer providing or selling the drug or device to a
  consumer:
               (1)  shall provide the disclosure form in person to the
  consumer; and
               (2)  may provide or sell the drug or device to the
  consumer only if a person capable of providing informed consent for
  the ultimate consumer of the drug or device signs the disclosure.
         (d)  A consumer who receives an experimental drug or device
  in violation of this section may bring an action against the
  manufacturer of the drug or device for damages arising from an
  adverse effect of the drug or device.
         (e)  A prevailing claimant in an action brought under
  Subsection (d) may recover:
               (1)  compensatory damages, including damages for
  physical and emotional pain and suffering;
               (2)  exemplary damages; and
               (3)  reasonable attorney's fees and costs incurred in
  bringing the action.
         SECTION 2.  Section 431.118, Health and Safety Code, as
  added by this Act, applies only to a cause of action that accrues on
  or after the effective date of this Act.
         SECTION 3.  This Act takes effect September 1, 2025.